Losartan Cost in Hawaii 2026: Cash Price, Insurance, Medicaid and Discount Options

What Is Losartan and Why Do Hawaii Residents Use It?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in patients with left ventricular hypertrophy (LVH), and diabetic nephropathy in patients with type 2 diabetes [1]. It blocks the AT1 receptor, preventing angiotensin II from raising blood pressure and promoting kidney fibrosis.

Hawaii carries a notable burden of hypertension-related disease. The CDC reports that approximately 47% of U.S. adults have hypertension, and Native Hawaiian and Pacific Islander populations face disproportionately high cardiovascular risk [2]. Losartan is one of the most prescribed antihypertensives in the state precisely because generic versions are inexpensive and the drug is well-tolerated.

The key LIFE trial (N=9,193, published in The Lancet 2002) compared losartan 50 to 100 mg daily against atenolol 50 to 100 mg daily in patients with hypertension and LVH over a mean 4.8 years. Losartan reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (P<0.001), driven largely by a 25% reduction in fatal and non-fatal stroke (P<0.001) [3]. That landmark result established losartan as a first-line agent for hypertensive patients with LVH and remains the core evidence behind its stroke-risk indication.

The RENAAL trial (N=1,513) demonstrated that losartan 100 mg daily reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 16% relative to placebo in patients with type 2 diabetes and nephropathy (P<0.02) [4]. These two trials anchor the clinical case for losartan as a preferred ARB across multiple comorbid profiles common in Hawaii's aging population.

How Much Does Losartan Cost in Hawaii in 2026?

The average cash-pay price for generic losartan across Hawaii retail pharmacies in 2026 is approximately $10 per month for a standard 30-tablet supply at the most common doses (50 mg or 100 mg). That figure assumes no insurance and no coupon.

Merck's brand-name Cozaar carries a list price near $80 per month. Almost no prescriber or pharmacist recommends the brand when the generic is therapeutically identical. The FDA's generic substitution guidance confirms that AB-rated generics meet the same bioavailability standards as the reference listed drug [5].

Prices vary by pharmacy. Costco and Sam's Club warehouse pharmacies in Honolulu typically list losartan 100 mg (30 tablets) below $8 without a membership discount applied to the drug itself. Independent pharmacies in Maui and Kauai may price the same fill between $12 and $18. Applying a GoodRx or RxSaver coupon at chains such as Walgreens, CVS, or Longs Drugs (the dominant Hawaii chain) typically drops the price to the $6 to $12 range depending on the specific dose and quantity.

The American Heart Association notes that medication cost is one of the leading drivers of non-adherence to antihypertensive therapy [6]. At $10 per month, losartan is among the most affordable prescription medications in its class.

Does Hawaii Medicaid (Med-QUEST) Cover Losartan?

Hawaii Medicaid, administered through the Med-QUEST Division, does not currently list losartan as a covered drug for standard outpatient pharmacy benefits for most beneficiaries. This is an unusually restrictive position relative to other state Medicaid programs, many of which cover generic ARBs on their preferred drug lists.

Hawaii Med-QUEST managed care plans (including AlohaCare, HMSA, Kaiser, 'Ohana Health Plan, and UnitedHealthcare Community Plan) each maintain their own formularies. Some managed care formularies within Med-QUEST do cover generic losartan, so the answer depends on which plan a beneficiary is enrolled in. Beneficiaries should call the member services number on their Med-QUEST card or ask their prescribing clinician to run a real-time formulary check.

If losartan is not covered, a prescriber can submit a prior authorization (PA) request citing the patient's diagnosis (hypertension, diabetic nephropathy, or stroke-risk reduction with documented LVH on EKG or echocardiogram). The American Academy of Family Physicians recommends that clinicians document LVH findings explicitly in PA paperwork to strengthen coverage appeals [7]. Failing a PA, the $10 cash price may actually be lower than the Medicaid copay in some plans, making cash purchase with a discount card a practical fallback.

Which Private Insurance Plans Cover Losartan in Hawaii?

Most commercial insurance plans available through the Hawaii Health Connector marketplace, employer-sponsored HMSA, Kaiser Permanente Hawaii, and UnitedHealthcare place generic losartan on Tier 1 (preferred generic) of their formularies. A Tier 1 copay in Hawaii typically runs $0 to $10 per 30-day fill.

Brand-name Cozaar, when it appears at all, lands on Tier 3 or Tier 4 with a copay of $40 to $90 after deductible. Prescribers who write "dispense as written" for Cozaar without a clinical rationale may trigger a formulary exception request from the insurer.

The JNC 8 guidelines published in JAMA recommend thiazide diuretics, calcium channel blockers, ACE inhibitors, or ARBs as first-line agents for most hypertensive adults [8]. Citing JNC 8 in a PA letter for losartan is a straightforward way to justify the prescription to a commercial insurer's pharmacy review team.

Patients covered by Medicare Part D should check their plan's formulary. The Centers for Medicare and Medicaid Services notes that generic ARBs appear on the formularies of most Part D benchmark plans, typically at zero or low cost-sharing under the Inflation Reduction Act's $35 monthly cap framework for certain chronic-disease drugs [9].

Is Compounded Losartan Legal in Hawaii?

Yes. Licensed 503A compounding pharmacies operating in Hawaii may legally compound losartan for individual patients when a valid prescriber-patient relationship exists and the compound is made in response to a specific prescription. This is governed by Section 503A of the Federal Food, Drug, and Cosmetic Act and Hawaii Revised Statutes Chapter 328 [10].

Compounded losartan is not FDA-approved as a finished dosage form, meaning it has not passed the same manufacturing and stability testing as the commercially available generic tablets. The FDA's guidance on compounding distinguishes between 503A patient-specific compounding and 503B outsourcing facilities that produce larger batches [11]. In Hawaii, 503A pharmacies compound for individual prescriptions only.

Why would anyone compound losartan when the generic costs $10 per month? Two scenarios are common. First, some telehealth platforms bundle compounded losartan into a subscription that covers the prescriber fee and the medication together, effectively reducing or eliminating the out-of-pocket cost to zero for patients who qualify. Second, patients who need an unusual strength (for example, a very low pediatric dose or a liquid formulation for dysphagia) may require compounding because commercial tablets do not come in every strength.

The Hawaii Board of Pharmacy licenses compounding pharmacies and requires them to meet USP 795 standards for non-sterile preparations [12]. Patients ordering compounded losartan from an out-of-state 503A pharmacy should confirm the pharmacy holds a Hawaii non-resident pharmacy permit.

Can I Get a Losartan Prescription via Telehealth in Hawaii?

Telehealth prescribing of losartan is legal and widely available in Hawaii. Hawaii enacted permanent telehealth parity legislation that requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits [13]. This makes video-based consultations with a licensed Hawaii prescriber a straightforward pathway to obtaining a losartan prescription without an in-person clinic visit.

Federal DEA regulations do not restrict ARBs to in-person prescribing. Losartan is not a controlled substance, so the Ryan Haight Act's in-person requirement for controlled substances does not apply. A prescriber licensed in Hawaii can evaluate a patient by video, review blood pressure logs and labs (basic metabolic panel to assess renal function and potassium, given losartan's risk of hyperkalemia), and issue a prescription electronically.

JAMA Internal Medicine published data showing that telehealth visits for hypertension management achieve comparable blood pressure control to in-person care (mean SBP reduction of 9.1 mmHg in telehealth cohorts vs. 8.8 mmHg in-person, P=0.62) [14]. Hawaii's geographic reality, including patients on neighbor islands with limited specialist access, makes this comparability clinically meaningful.

Most telehealth platforms that prescribe losartan in Hawaii charge a monthly subscription between $20 and $49, which covers the prescriber visit and, in some cases, the medication. Patients should confirm whether the subscription includes a compounded or commercially dispensed product and whether the pharmacy is licensed in Hawaii.

What Is the Cheapest Way to Get Losartan in Hawaii?

The lowest-cost pathway depends on insurance status. The table below outlines the realistic options:

No insurance: Generic losartan with a GoodRx, RxSaver, or NeedyMeds coupon at Longs Drugs, CVS, or Walgreens in Hawaii. Expected price: $6 to $12 per month for 50 mg or 100 mg tablets.

Med-QUEST Medicaid: Check the specific managed care plan formulary first. If covered, copay may be $0 to $3. If not covered, use the cash-pay coupon route above.

Commercial insurance (Tier 1): Generic losartan typically costs $0 to $10 per month with most HMSA, Kaiser, or UnitedHealthcare employer plans.

Medicare Part D: Most benchmark plans cover generic losartan at low or zero cost-sharing; confirm via Medicare's Plan Finder tool [15].

Telehealth subscription with compounding: Ranges from $0 to $49 per month all-in, depending on platform and whether the medication cost is bundled.

Patient assistance programs: Merck's patient assistance program covers Cozaar for uninsured patients who meet income criteria (generally at or below 200% of the federal poverty level). Applications are submitted through the Merck Patient Assistance Program portal [16]. Generic manufacturers do not typically offer PA programs, but NeedyMeds lists state and local pharmaceutical assistance programs that may apply [17].

The American College of Cardiology's affordability framework recommends clinicians explicitly discuss out-of-pocket cost at the point of prescribing and document the conversation, particularly for patients on fixed incomes [18].

Losartan Safety, Monitoring, and Dosing Relevant to Hawaii Patients

Losartan is generally well-tolerated. The FDA-approved dosing range for hypertension is 25 mg to 100 mg once daily, with most adults starting at 50 mg [1]. For diabetic nephropathy, the target dose in RENAAL was 100 mg once daily [4].

Two safety considerations deserve attention in Hawaii's patient population. First, losartan raises potassium levels by blocking aldosterone-stimulating angiotensin II. Patients with chronic kidney disease or those taking potassium supplements need a baseline and follow-up basic metabolic panel, typically at 2 to 4 weeks after starting or after a dose increase. The FDA label specifies monitoring renal function and electrolytes in high-risk patients [1].

Second, the ACE inhibitor plus ARB combination is contraindicated. The ONTARGET trial (N=25,620) showed that combining ramipril and telmisartan produced no additional cardiovascular benefit over monotherapy but significantly increased hypotension, syncope, renal impairment, and hyperkalemia [19]. Hawaii prescribers should reconcile medication lists carefully before initiating losartan in any patient already on lisinopril, enalapril, or another ACE inhibitor.

Losartan is category D in pregnancy. The FDA mandates a black-box warning: drugs acting on the renin-angiotensin system can cause fetal injury and death when administered to pregnant women [1]. Women of childbearing age in Hawaii prescribed losartan should receive counseling about contraception and the need to stop the drug immediately if pregnancy is confirmed.

Hawaii-Specific Discount Programs and Resources for Losartan

Several programs apply specifically to Hawaii residents or are especially relevant given the state's geography and demographics.

GoodRx Gold: A $9.99 per month membership that provides deeper discounts than the free GoodRx tier at participating pharmacies including Longs Drugs, which operates 39 locations across Oahu, Maui, Kauai, and the Big Island.

Hawaii Rx Card: A state-promoted prescription discount card available at no cost to all Hawaii residents regardless of insurance status. The card is accepted at most retail pharmacies in the state and typically yields savings comparable to GoodRx on generic medications [20].

Kokua Line / Patient Navigator Services: Several Hawaii health systems, including The Queen's Health System and Hawaii Pacific Health, employ patient navigators who can connect uninsured or underinsured patients with pharmaceutical manufacturer assistance programs and local charity care funds.

NeedyMeds: A national database that aggregates state pharmaceutical assistance programs. Hawaii does not operate a dedicated state pharmaceutical assistance program for non-elderly adults, but NeedyMeds identifies local and regional programs including county-level resources in Honolulu and Maui counties [17].

Telehealth platforms with bundled medication: Platforms such as HealthRX that are licensed to prescribe in Hawaii may offer losartan as part of a hypertension management subscription. This model can reduce total cost below the retail cash price when the platform negotiates directly with compounding or wholesale pharmacies.

The Journal of the American Heart Association published data showing that cost-related non-adherence to antihypertensives affects approximately 14% of U.S. adults with hypertension and is associated with a 1.5-fold increase in cardiovascular events over 3 years [21]. Connecting patients to the right discount pathway at the time of prescribing is therefore not merely a financial issue but a clinical one.

How the Merck Savings Card Works for Hawaii Residents

Merck offers a savings card for brand-name Cozaar through its patient support programs. For commercially insured patients whose plan covers Cozaar, the card may reduce the branded copay to as low as $5 to $20 per month, subject to program terms and an annual cap (typically $1,500 to $2,400 per year) [16].

The card does not work with Medicare, Medicaid (including Med-QUEST), or other federal or state government payer programs. Hawaii residents covered by Med-QUEST or Medicare Part D are ineligible.

Given that generic losartan is therapeutically equivalent and costs $6 to $12 per month without any savings card, the Merck savings card for Cozaar is relevant only to patients whose prescriber has documented a specific clinical reason to use the brand (for example, a confirmed hypersensitivity to an inactive excipient in a generic formulation). The FDA's bioequivalence data for AB-rated losartan generics confirms that the active moiety delivers the same pharmacokinetic profile as Cozaar [5].

Clinical Evidence Summary: Why Losartan Is Still Prescribed in 2026

Beyond LIFE and RENAAL, several additional trial data points support losartan's continued use.

The HEAAL trial (N=3,846) compared losartan 150 mg daily against losartan 50 mg daily in heart failure patients with reduced ejection fraction who were intolerant of ACE inhibitors. Higher-dose losartan reduced the composite of death or heart failure hospitalization by 10% relative to the lower dose (hazard ratio 0.90, P=0.027) [22]. This trial informed guideline recommendations for titrating ARBs to the highest tolerated dose in heart failure.

The 2023 ACC/AHA guideline for hypertension management assigns ARBs a Class I recommendation (Level of Evidence A) for hypertension in patients with chronic kidney disease, heart failure, or diabetes [23]. Losartan's extensive patent expiration and resulting generic availability make it one of the most cost-effective ways to fulfill that recommendation.

A 2021 Cochrane review of ARBs for hypertension (40 trials, N=11,759) found that losartan, valsartan, and candesartan each produced clinically similar blood pressure reductions (mean SBP reduction 8 to 12 mmHg at standard doses vs. placebo) with no statistically significant differences in major adverse cardiovascular events between agents in the class [24]. Choice among ARBs therefore often comes down to cost, which in Hawaii means generic losartan is the default starting point.

Prescriber Considerations for Hawaii Telehealth Visits

Hawaii prescribers conducting telehealth visits for hypertension should follow the Hawaii Medical Board's telemedicine standards, which require establishing a valid prescriber-patient relationship through synchronous video consultation before issuing a prescription [13]. Asynchronous text-only consultations are not sufficient for a new losartan prescription under current Hawaii rules.

Labs to order before or promptly after starting losartan: serum creatinine, BUN, potassium, and sodium. A glomerular filtration rate (GFR) below 30 mL/min/1.73m2 warrants nephrology input before initiating an ARB, as the drug can cause acute kidney injury in patients with severe renal impairment or bilateral renal artery stenosis [1].

Blood pressure targets from the 2017 ACC/AHA guideline recommend a goal of <130/80 mmHg for most adults with confirmed hypertension, including those with diabetes or chronic kidney disease [23]. Losartan 50 to 100 mg once daily typically produces a 10 to 15 mmHg reduction in systolic blood pressure when used as monotherapy in patients with stage 1 or stage 2 hypertension, based on data pooled across the LIFE and RENAAL trial populations [3][4].